DNA Methylation as a Biomarker for Body Fluid Identification
نویسندگان
چکیده
منابع مشابه
DNA Methylation as a Biomarker for Cardiovascular Disease Risk
BACKGROUND Elevated serum homocysteine is associated with an increased risk of cardiovascular disease (CVD). This may reflect a reduced systemic remethylation capacity, which would be expected to cause decreased genomic DNA methylation in peripheral blood leukocytes (PBL). METHODOLOGY/PRINCIPAL FINDINGS We examined the association between prevalence of CVD (myocardial infarction, stroke) and ...
متن کاملSalivary DNA Methylation Profiling: Aspects to Consider for Biomarker Identification
Is it not more comfortable to spit saliva in a tube than to be pricked with a needle to draw blood to analyse your health and disease risk? Many patients, study participants and (parents of) young children undoubtedly prefer non-invasive and convenient procedures. Such procedures increase compliance rates especially for longitudinal prospective studies. Saliva is an attractive biofluid providin...
متن کاملA collaborative exercise on DNA methylation based body fluid typing.
A collaborative exercise on DNA methylation based body fluid identification was conducted by seven laboratories. For this project, a multiplex methylation SNaPshot reaction composed of seven CpG markers was used for the identification of four body fluids, including blood, saliva, semen, and vaginal fluid. A total of 30 specimens were prepared and distributed to participating laboratories after ...
متن کاملDNA Methylation in Circulating Tumour DNA as a Biomarker for Cancer
Free circulating DNA, which is thought to be derived from the primary tumour, can be detected in the blood of patients with cancer. Detection of genetic and epigenetic alteration in this tumour DNA offers a potential source of development of prognostic and predictive biomarkers for cancer. One such change is DNA methylation of the promotor region of tumour suppressor genes. This causes down reg...
متن کاملIdentification of specific DNA methylation sites on the Y-chromosome as biomarker in prostate cancer
As a diagnostic biomarker, prostate special antigen (PSA) tests always generate false positive results and lead to unnecessary and/or repeat biopsies. Therefore, there is an urgent need for developing more sensitive, specific diagnostic biomarkers. We epigenotyped methylated sites in cancer tissues and adjacent normal tissues from 66 patients. In comparison with normal adjacent tissues, we obse...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Arab Journal of Forensic Sciences and Forensic Medicine
سال: 2017
ISSN: 1658-6786,1658-6794
DOI: 10.26735/16586794.2017.001